Agonist-induced hump current production in heterologously-expressed human α4β2-nicotinic acetylcholine receptors

Abstract

Aim: To characterize the functional and pharmacological features of agonist-induced hump currents in human α4β2-nicotinic acetylcholine receptors (nAChR). Methods: Whole-cell and outside-out patch recordings were performed using human α4β2-nAChR heterologously expressed in stably-transfected, native nAChR-null subclonal human epithelial 1 (SH-EP1) cells. RT-PCR was used to test the mRNA expression of transfected nAChR. Homology modeling and acetylcholine (ACh) docking were applied to show the possible ACh-binding site in the channel pore. Results: The rapid exposure of 10 mmol/L ACh induced an inward current with a decline from peak to steady-state. However, after the removal of ACh, an additional inward current, called "hump" current, reoccurred. The ability of agonists to produce these hump currents cannot be easily explained based on drug size, charge, acute potency, or actions as full or partial agonists. Hump currents were associated with a rebound increase in whole-cell conductance, and they had voltage dependence-like peak currents induced by agonist action. Hump currents blocked by the α4β2-nAChR antagonist dihydro-β-erythroidine were reduced when α4β2-nAChR were desensitized, and were more pronounced in the absence of external Ca 2+. Outside-out single-channel recordings demonstrated that compared to 1 µmol/L nicotine, 100 µmol/L nicotine reduced channel current amplitude, shortened the channel mean open time, and prolonged the channel mean closed time, supporting an agonist-induced open-channel block before hump current production. A docking model also simulated the agonist-binding site in the channel pore. Conclusion: These results support the hypothesis that hump currents reflect a rapid release of agonists from the α4β2-nAChR channel pore and a rapid recovery from desensitized α4β2-nAChR. Key wordsacetylcholine; dihyd r o -β-er y th r o id in e; dimethyl-phenyl-piperazinium; epibatidine; nicotinic acetylcholine receptor

A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties

“…It seems likely that this is a consequence of receptor/channel-blocking activity and is a feature that is also observed with high concentrations of orthosteric agonists such as acetylcholine, for which it has been described as a "hump current" (Liu et al, 2008). Among the agonists examined in the present study, we have seen a wide variation in the extent of this phenomenon.…”

Agonist activation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site

“…After the response to 4BP-TQS had reached a plateau, acetylcholine (25 μM) was coapplied with 4BP-TQS (10 μM), resulting in a secondary response of much greater magnitude (542 ± 32; n = 3) than was observed when the same concentration of acetylcholine was applied alone (Center). ceptor/channel-blocking activity, a feature that is also observed with high concentrations of conventional agonists, such as acetylcholine (31).…”

Functional and Structural Interaction of (−)-Reboxetine with the Human α4β2 Nicotinic Acetylcholine Receptor

“…In the experiments, ACh was applied as an agonist without atropine, because our experimental data showed that 1 mM atropine sulfate did not affect ACh-induced currents (not shown) and because atropine itself has been reported to block nAChRs (Liu et al, 2008). For all conventional whole-cell recordings, TRIS electrodes were used and filled with solution containing 110 mM TRIS phosphate dibasic, 28 mM TRIS base, 11 mM EGTA, 2 mM MgCl 2 , 0.1 mM CaCl 2 , and 4 mM Mg-ATP (pH, 7.3).…”